학술논문
SRX3177, a CDK4/6-PI3K-BET inhibitor, in combination with an RdRp inhibitor, Molnupiravir, or an entry inhibitor MU-UNMC-2, has potent antiviral activity against the Omicron variant of SARS-CoV-2
Document Type
Short Communication
Author
Source
In Antiviral Research July 2024 227
Subject
Language
ISSN
0166-3542